Nigerian Canadian Newspaper Canada
For advert, please contact
publisher@nigeriancanadiannews.ca
1 (416) 318-3506
  • Home
  • World News
    • Africa
      • Nigeria
        • #EndSARS
        • #NigeriaDecides2019
        • Nigerian News
      • Ghana
    • North America
      • USA
      • Canadian News
    • Europe
  • Monthly Edition
  • Business
    • Business & Investment
    • Business News
    • Personal Finance
  • Government & Politics
  • Law
  • Opinion
    • Columnist
    • Editorial
  • Health
    • Canada Health
  • Lifestyle
    • Relationships
    • Technology
    • Religion
    • Sports
    • Beauty/Fashion
    • Family
    • Entertainment
    • Career
    • Food/Drinks
    • Home & Property
    • Social Phychology
  • Community
    • Churches
    • Events
    • Obituaries
    • Contact us
    • Archives
No Result
View All Result
  • Home
  • World News
    • Africa
      • Nigeria
        • #EndSARS
        • #NigeriaDecides2019
        • Nigerian News
      • Ghana
    • North America
      • USA
      • Canadian News
    • Europe
  • Monthly Edition
  • Business
    • Business & Investment
    • Business News
    • Personal Finance
  • Government & Politics
  • Law
  • Opinion
    • Columnist
    • Editorial
  • Health
    • Canada Health
  • Lifestyle
    • Relationships
    • Technology
    • Religion
    • Sports
    • Beauty/Fashion
    • Family
    • Entertainment
    • Career
    • Food/Drinks
    • Home & Property
    • Social Phychology
  • Community
    • Churches
    • Events
    • Obituaries
    • Contact us
    • Archives
No Result
View All Result
Nigerian Canadian Newspaper Canada
No Result
View All Result
Home Community

New antibiotics cannot combat growing threat of antimicrobial resistance – WHO

NigerianCanadianNews by NigerianCanadianNews
September 23, 2017
in Community, Health, News, World News
0 0
0

“Most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions. “Antimicrobial resistance is a global health emergency that will seriously jeopardize progress in modern medicine,” WHO Director-General, Tedros Adhanom, said in a statement on Thursday in New York.
“The report found very few potential treatment options for those antibiotic-resistant infections identified by WHO as posing the greatest threat to health, including drug-resistant tuberculosis which kills around 250,000 people each year. “There is an urgent need for more investment in research and development for antibiotic-resistant infections including Tuberculosis (TB).
“Otherwise, we will be forced back to a time when people feared common infections and risked their lives from minor surgery,” Adhanom said. According to him, in addition to multidrug-resistant tuberculosis, WHO has identified 12 classes of priority pathogens.
Some of them causing common infections such as pneumonia or urinary tract infections that are increasingly resistant to existing antibiotics and urgently in need of new treatments. Also, Suzanne Hill, the Director, Department of Essential Medicines at WHO, said that the report identifies 51 new antibiotics and biological in clinical development.
According to Hill, this is to treat priority antibiotic-resistant pathogens, as well as tuberculosis and sometimes deadly diarrhoea infection Clostridium difficile. “Among all these candidate medicines, however, only eight are classed by WHO as innovative treatments that will add value to the current antibiotic treatment arsenal. “There is a serious lack of treatment options for multidrug- and extensively drug-resistant M. tuberculosis and gram-negative pathogens. “This includes Acinetobacter and Enterobacteriaceae (such as Klebsiella and E.coli) which can cause severe and often deadly infections that pose a particular threat in hospitals and nursing homes.
“The report also found that though, oral antibiotics are essential for treatment outside hospitals or in resource-limited settings, few are in the pipeline. “Pharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections that can kill patients in a matter of days. “This is because, we have no line of defence,” Hill said. To counter this threat, WHO and the Drugs for Neglected Diseases Initiative (DNDi) set up a research and development partnership.
According to Mario Raviglione, the Director of the WHO Global Tuberculosis Programme, said that research for tuberculosis was seriously underfunded, with only two new antibiotics for treatment of drug-resistant tuberculosis having reached the market in over 70 years. “If we are to end tuberculosis, more than 800 million dollars per year is urgently needed to fund research for new anti-tuberculosis medicines,” he said.

Post Views: 283
Tags: WHO
ShareSendShareSend
NigerianCanadianNews

NigerianCanadianNews

Related Posts

One-stop health care at your local pharmacy
Health

One-stop health care at your local pharmacy

March 21, 2023
5 common ailments you can treat at the pharmacy
Health

5 common ailments you can treat at the pharmacy

March 21, 2023
175,000 Cancellations Made Due To Junior Doctors’ Strike
Health

175,000 Cancellations Made Due To Junior Doctors’ Strike

March 20, 2023
Next Post

5 reasons why many kids wear eyeglasses

OPEC exempts Nigeria from oil production cut

We don’t see IPOB as terrorist organisation – US

March 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Feb    

Health

Lifestyle

Community

Sports

Worldwide

Contact Us

Quick Link

  • Home
  • Advertise
  • Careers
  • Monthly Edition
  • Home & Property
  • World News

Recent News

  • The Vindication of Mazi Nnamdi Kanu and the Biafra Question March 22, 2023
  • Share a problem – What is expected of a woman in marriage? March 22, 2023
  • Earthquake hits Afghanistan, kills three and injures dozens March 22, 2023

© 2023 Nigerian Canadian Newspaper Canada. Powered by NASCI.

No Result
View All Result
  • World
    • Africa
      • Nigeria
    • North America
      • Canadian News
      • USA
  • Monthly Edition
  • Business
    • Business & Investment
    • Business News
    • Personal Finance
  • Government & Politics
  • Law
  • Opinion
    • Columnist
    • Editorial
  • Health
  • Lifestyle
    • Religion
    • Technology
    • Sports
    • Beauty/Fashion
    • Relationships
    • Food/Drinks
    • Home & Property
  • Community
    • Events
    • Churches
    • Obituaries

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Cleantalk Pixel
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT